Vaccines major Bharat Biotech International Ltd on Tuesday said it has entered into a collaboration with the University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
The company has signed a Memorandum of Understanding with the University of Sydney Infectious Diseases Institute for the collaboration that aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to tackle future epidemics and infectious diseases, Bharat Biotech said in a statement.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Furthermore, the collaboration will also leverage academia-industry strengths for advancing the science of vaccines and biotherapeutics, it added.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
"This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology," Bharat Biotech Executive Chairman Krishna Ella said.
The collaboration will "leverage the prowess of education, research capabilities to help build a healthier universe and improve people's lives by developing safer vaccine platforms," he said, adding, "most importantly, (it will help) build the talent of young scientists with a passion to innovate."
Sydney ID Deputy Director Professor Jamie Triccas said, "The reputational and societal impacts of developing novel vaccines to eradicate human and animal diseases that are safe, affordable, and effective cannot be overstated. Together with Bharat Biotech International Ltd, we aim to make a lasting impact on global health."
Bharat Biotech had played a key role in the combat against COVID-19 with its indigenously developed COVAXIN.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
